null
100% Quality Guarantee
PhD-Level Technical Support
Key Features

Human Cancer Discovery Array (20 targets) (SARB0028)

SKU SARB0028
Product Type Protein Array
Analytes Alpha-fetoprotein
Analytes Beta-2 Microglobulin
Analytes CA125
Analytes CA19-9
Analytes CEA
Analytes CRP (C-Reactive Protein)
Analytes DKK-1
Analytes Ferritin
Analytes Galectin-3
Analytes GDF-15
Analytes HGF
Analytes ICAM-1 (CD54)
Analytes IL-8 (CXCL8)
Analytes MMP-2
Analytes Osteopontin (SPP1)
Analytes PAI-1
Analytes PSA-free
Analytes RANTES (CCL5)
Analytes TIMP-1
Analytes VEGF-A
Reactivity Human
Applications Multiplex Array
€839 - €1,667
Global Shipping: 80+ Countries
White Glove Service: Available upon request
Batch Consistency: Contact Sales
Distributors: 60+ Countries

Description

system_update_altDatasheet

Human Cancer Discovery Array (20 targets) (SARB0028)

The Human Cancer Discovery Array (SARB0028) offered by Assaygenie is a powerful tool for researchers conducting studies on cancer and immune regulation. This array targets 20 key proteins involved in cancer development and immune response, providing valuable insights into the molecular mechanisms underlying these processes.With a focus on immune regulation, this array includes targets such as CD300A, a cell surface molecule known for its role in inhibiting immune responses. By detecting and analyzing the expression levels of these key proteins, researchers can gain a better understanding of the complex interplay between the immune system and cancer cells.

The Human Cancer Discovery Array is suitable for a wide range of applications, including Western blotting and other protein detection techniques. With its high reactivity towards human samples, researchers can trust the accuracy and reliability of their results when using this array.Overall, the Human Cancer Discovery Array (SARB0028) from Assaygenie is an invaluable tool for researchers seeking to unravel the complexities of cancer and immune regulation. By studying the expression patterns of key proteins involved in these processes, researchers can move closer to developing targeted therapies for cancer and other immune-related disorders.

0 Reviews

0
Based on 0 reviews

No reviews yet. Be the first to share your experience!

View AllClose